Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06809868 · ClinicalTrials.gov registry record
Role of Transposable Elements in Septic Immune Aging
A clinical trial of Sepsis and Sepsis, Severe, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 116
- Enrollment target
- 1
- Study location
NCT06809868 is a study of Sepsis and Sepsis, Severe that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 116 participants, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06809868, a study of Sepsis and Sepsis, Severe, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.
Conditions Studied
Interventions
- GENETIC RNA and DNA Sequencing
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2025-02-14 |
| Est. Completion | 2028-08-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06809868
The ClinicalTrials.gov registry entry for NCT06809868 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which RNA and DNA Sequencing is the first listed.
NCT06809868 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06809868 about?
NCT06809868 is a clinical study titled "Role of Transposable Elements in Septic Immune Aging". The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with i...
What is the current status of trial NCT06809868?
This trial is currently recruiting. The enrollment target is 116 participants. The study started on 2025-02-14. Estimated completion is 2028-08-14.
What conditions does trial NCT06809868 study?
This clinical trial studies the following conditions: Sepsis, Sepsis, Severe, Sepsis, Septic Shock, Sepsis and Septic Shock, Sepsis With Multiple Organ Dysfunction (MOD).
What interventions are being tested in trial NCT06809868?
The interventions under investigation include: RNA and DNA Sequencing (GENETIC).
Who is sponsoring clinical trial NCT06809868?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06809868 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.